JABET Explore more articles

Table 2. Summary of the animal studies relating to using herbal extracts in autistic-like rodents.

Induction of autistic-like model

Herb and dosage (route of administration)

Period of herbal treatment

Main effects of herbal treatment*

Ref.

SC injection of VPA (400 mg/kg) to mouse pups on PND 14

Camellia sinensis at 75 and 300 mg/kg/day (PO)

PND 13-40

Hyperactivity and anxiety-like behavior

Sensorimotor reflex

Spatial memory

Plasma levels of MDA

Cerebellar abnormalities (structural damage of Purkinje cells)

[27]

IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5

Camellia sinensis at 300 mg/kg/day (PO)

PND 15-34

Cerebellar and cortical levels of GABA and taurine

Cerebellar and cortical levels of glutamate

Cortical levels of serine

Brain levels of cholesterol, GSH, SOD, and CAT

Brain levels of MAO, AChE, MDA, NO, TNF-α and IL-6

[28]

IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5

Bacopa monniera at 300 mg/kg/day (PO)

PND 21-35

Hyperactivity and anxiety-like behavior

Sensorimotor reflex

Sociability

Hippocampal levels of total nitrite

Hippocampal levels of GSH and CAT

Cerebellar abnormalities (low number and structural damage of Purkinje cells)

[29]

IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5

Bacopa monniera at 20, 40, and 80 mg/kg/day (PO)

PND 23-43

Sociability and social preference

Anxiety-like and repetitive behaviors

Learning and memory

Motor coordination

Hippocampal and prefrontal levels of GSH, SOD, CAT and IL-10

Hippocampal and prefrontal levels of MDA, IL-1β, IL-6 and TNF-α

Hippocampal and prefrontal expression of AMPA receptor

Hippocampal and prefrontal abnormalities (structural damage of neuronal cells)

[30]

IP injection of VPA (500 mg/kg) to pregnant rats on GD 13

Asparagus racemosus at 50, 100, and 200 mg/kg/day (PO)

PND 21-35

Plasma levels of nitrite

Brain levels of GSH and CAT

Brain levels of MAO-A and AchE

[31]

SC injection of VPA (300 mg/kg) to pregnant mice on GD 10

Korean red ginseng at 100 and 200 mg/kg/day (PO)

PND 21-38

Sociability and social preference

Repetitive behavior and hyperactivity

Spatial working memory

Hypersensitivity to electric seizure

[32]

SC injection of VPA (400 mg/kg) to pregnant rats on GD 12

Korean red ginseng at 20, 50, 100, and 200 mg/kg/day (PO)

GD 10-15

Locomotor activity, sociability, and social preference

Hypersensitivity to electric seizure

Tail deformation (teratogenicity of VPA)

[33]

SC injection of VPA (400 mg/kg) to rat pups on PND 14

Oryza sativa at 50, 100, and 200 mg/kg/day (PO)

PND 14-40

Sensorimotor reflex

Anxiety-like and social avoidance behaviors

Spatial memory

Cerebellar levels of CAT, SOD, and GSH

Cerebellar levels of MDA

Cerebellar abnormalities (low density of Purkinje cells)

[34]

SC injection of VPA (400 mg/kg) to rat pups on PND 14

Morus alba at 25, 50, and 100 mg/kg/day (PO)

PND 14-40

Sensorimotor reflex

Social avoidance behavior

Spatial memory

Hippocampal levels of MDA

Hippocampal levels of CAT and GPx

Hippocampal abnormalities (low density of neuronal cells)

[35]

IP injection of VPA (600 mg/kg) to pregnant rats on GD 12.5

Prangos ferulacea (L.) at 100 and 200 mg/kg/day (IP)

PND 30-58

Hippocampal levels of MDA

Hippocampal levels of GSH and CAT

Hippocampal abnormalities (high percentage of neuronal death)

[36]

SC injection of VPA (600 mg/kg) to pregnant rats on GD 12.5

Passiflora incarnata at 30, 100, and 300 mg/kg in drinking water (PO)

PND 35-81

Sociability and social preference

Anxiety-like and repetitive behaviors

Recognition memory

Serum levels of CAT, SOD, and TAC

Serum levels of MDA

Cerebral abnormalities (high number of

 damaged neurons in the PFC and hippocampal CA1 areas)

[37]

IG gavage of VPA (400 mg/kg) to mouse pups on PND 14-16

Ziziphus talanai (Blanco) Merr. at 300 and 400 mg/kg/day (PO)

PND 14-16

Locomotor behavior

Cerebellar abnormalities (structural damage of Purkinje cells)

[38]

SC injection of VPA (400 mg/kg) to mouse pups on PND 14

Ginkgo biloba at 100 mg/kg/day (IP)

PND 13-40

Serum levels of IL-17

Brain levels of MDA and IL-6

Brain levels of GSH and TGF-β1

Cerebellar levels of MBP and serotonin

Cerebellar abnormalities (low number of Purkinje cells)

[39]

ICV infusion of PPA (4 µl of a 0.26 M solution) to male rats for 7 days (not specified)

Clitoria ternatea L. at 250 and 500 mg/kg/day (PO)

Not specified (treatment lasted for 28 days)

Novel object recognition

Learning and memory

Brain levels of serotonin and glutamate

[40]

Relative to the autistic-like animals not given herbal treatment (, increase; , decrease). Only statistically significant findings are mentioned. VPA, valproic acid; PPA, propionic acid; SC, subcutaneous; PO, per oral; PND, postnatal day; IP, intraperitoneal; GD, gestational day; IG, intragastric; ICV, intracerebroventricular.